Tan-awon, Editha M.
HRN: 09-83-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2024
CO-AMOXICLAV 625MG (TAB)
03/14/2024
03/20/2024
PO
1 Cap
BID
SP NSVD With Perineal Swelling
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes